Regenxbio reported a net margin of 21.01% for the quarter ended Jun 2026. These financial ratios cover 47 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 55.44% | 54.16% | 94.22% | 29.26% | 60.33% | 50.61% | 59.22% | 78.51% | 52.57% | 57.16% | 49.41% | 72.58% | 52.55% | 48.81% | 70.22% | ||||||||||||||||||||||||||||||||
| EBT Margin | -261.58% | -189.79% | 77.13% | -345.50% | -208.82% | -284.72% | -191.35% | -348.40% | -360.72% | -213.97% | -283.80% | -405.63% | -237.80% | -246.40% | -241.68% | 6.81% | -331.91% | -208.39% | -221.40% | 21.01% | |||||||||||||||||||||||||||
| EBIT Margin | -237.01% | -186.36% | 78.66% | -321.93% | -191.53% | -267.97% | -184.31% | -345.68% | -365.96% | -224.67% | -287.68% | -408.80% | -251.34% | -256.55% | -242.14% | 13.62% | -296.26% | -176.27% | -189.99% | 27.09% | |||||||||||||||||||||||||||
| EBITDA Margin | -237.01% | -186.36% | 78.66% | -321.93% | -191.53% | -267.97% | -184.31% | -345.68% | -365.96% | -224.67% | -287.68% | -408.80% | -251.34% | -256.55% | -242.14% | 13.62% | -296.26% | -176.27% | -189.99% | 27.09% | |||||||||||||||||||||||||||
| Operating Margin | -237.01% | -186.36% | 78.66% | -321.93% | -191.53% | -267.97% | -184.31% | -345.68% | -365.96% | -224.67% | -287.68% | -408.80% | -251.34% | -256.55% | -242.14% | 13.62% | -296.26% | -176.27% | -189.99% | 27.09% | |||||||||||||||||||||||||||
| Net Margin | -261.58% | -189.79% | 73.75% | -345.32% | -208.82% | -284.72% | -3.62% | -348.40% | -360.72% | -213.97% | -283.80% | -405.63% | -237.80% | -246.40% | -241.68% | 6.81% | -331.91% | -208.39% | -221.40% | 21.01% | |||||||||||||||||||||||||||
| FCF Margin | -253.75% | -198.88% | 82.00% | -301.01% | -217.42% | -209.36% | -143.06% | -447.99% | -249.78% | -175.85% | -188.57% | -351.20% | -198.37% | -180.88% | -154.16% | 36.63% | -216.29% | -201.75% | -174.04% | ||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 857.92M | 818.40M | 957.15M | 1,069.64M | 989.41M | 918.62M | 858.53M | 790.55M | 715.14M | 658.12M | 603.88M | 601.59M | 599.30M | 544.25M | 492.55M | 478.46M | 535.98M | 553.12M | 489.12M | 419.82M | |||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | |||||||||||||||||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.19 | 0.11 | 0.49 | 0.44 | 0.49 | 0.52 | 0.13 | 0.14 | 0.14 | 0.15 | 0.15 | 0.14 | 0.15 | 0.15 | 0.17 | 0.33 | 0.29 | 0.29 | 0.35 | 0.45 | |||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -8.20 | -8.55 | 48.25 | -11.67 | -9.12 | -11.93 | -13.40 | -24.01 | -65.28 | -40.00 | -46.88 | -32.37 | -124.80 | -75.70 | -5.45 | 1.42 | -5.76 | -3.98 | -4.70 | 3.76 | |||||||||||||||||||||||||||
| Debt Ratio | |||||||||||||||||||||||||||||||||||||||||||||||
| Times Interest Earned | -8.20 | -8.55 | 48.25 | -11.67 | -9.12 | -11.93 | -13.40 | -24.01 | -65.28 | -40.00 | -46.88 | -32.37 | -124.80 | -75.70 | -5.45 | 1.42 | -5.76 | -3.98 | -4.70 | 3.76 | |||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -28.68 | -30.69 | 4.76 | -18.59 | -15.64 | -15.16 | -865.98 | -12.33 | -12.10 | -11.70 | -12.54 | -16.31 | -10.88 | -8.72 | -7.47 | 59.15 | -5.84 | -7.88 | -10.91 | 28.60 | |||||||||||||||||||||||||||
| Price to SalesP/S | 75.03 | 58.24 | 3.51 | 64.21 | 32.66 | 43.16 | 31.33 | 42.95 | 43.65 | 25.04 | 35.59 | 66.15 | 25.88 | 21.47 | 18.05 | 4.03 | 19.37 | 16.43 | 24.16 | 6.01 | |||||||||||||||||||||||||||
| Price to BookP/B | 3.26 | 3.88 | 1.83 | 2.07 | 1.69 | 2.03 | 1.90 | 1.77 | 2.15 | 1.99 | 2.54 | 2.65 | 1.66 | 1.72 | 1.48 | 1.31 | 1.94 | 3.03 | 7.13 | 9.04 | |||||||||||||||||||||||||||
| Enterprise Value | 1,278.52M | 1,452.30M | 943.13M | 1,032.44M | 663.36M | 761.79M | 617.38M | 490.11M | 551.90M | 422.20M | 515.37M | 694.63M | 286.65M | 264.15M | 148.33M | 90.47M | 334.14M | 214.27M | 502.77M | 543.37M | |||||||||||||||||||||||||||
| EV to EBIT | -24.48 | -25.32 | 3.01 | -14.43 | -10.61 | -10.72 | -10.69 | -7.41 | -7.55 | -6.50 | -8.06 | -10.88 | -5.12 | -4.26 | -2.89 | 7.46 | -5.28 | -4.09 | -8.72 | 18.57 | |||||||||||||||||||||||||||
| EV to EBITDA | -24.48 | -25.32 | 3.01 | -14.43 | -10.61 | -10.72 | -10.69 | -7.41 | -7.55 | -6.50 | -8.06 | -10.88 | -5.12 | -4.26 | -2.89 | 7.46 | -5.28 | -4.09 | -8.72 | 18.57 | |||||||||||||||||||||||||||
| Market Capitalization | 1,653.26M | 1,792.16M | 1,400.57M | 1,426.57M | 1,066.32M | 1,144.21M | 982.02M | 821.92M | 871.98M | 724.09M | 790.63M | 1,033.34M | 577.01M | 519.61M | 383.01M | 358.34M | 413.69M | 488.47M | 732.84M | 648.88M | |||||||||||||||||||||||||||
| Price to FCFP/FCF | -29.57 | -29.28 | 4.28 | -21.33 | -15.02 | -20.61 | -21.90 | -9.59 | -17.47 | -14.24 | -18.88 | -18.83 | -13.05 | -11.87 | -11.71 | 10.99 | -8.95 | -8.14 | -13.88 | ||||||||||||||||||||||||||||
| EV to FCF | -22.87 | -23.73 | 2.89 | -15.44 | -9.34 | -13.72 | -13.77 | -5.72 | -11.06 | -8.30 | -12.30 | -12.66 | -6.48 | -6.04 | -4.54 | 2.77 | -7.23 | -3.57 | -9.52 | ||||||||||||||||||||||||||||
| EV to CFO | -35.44 | -34.17 | 2.76 | -18.47 | -10.74 | -15.10 | -15.68 | -6.06 | -11.66 | -8.55 | -12.64 | -12.53 | -6.30 | -6.51 | -4.69 | 2.69 | -6.77 | -3.83 | -9.62 | ||||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -237.01% | -186.36% | 78.66% | -321.93% | -191.53% | -267.97% | -184.31% | -345.68% | -365.96% | -224.67% | -287.68% | -408.80% | -251.34% | -256.55% | -242.14% | 13.62% | -296.26% | -176.27% | -189.99% | 27.09% | |||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -17.74% | -29.13% | 19.35% | 13.95% | 13.97% | 13.65% | -36.10% | -37.97% | -44.89% | -49.36% | -56.61% | -54.10% | -49.65% | -55.69% | -59.93% | -42.33% | -39.52% | -36.15% | -43.45% | -42.72% | |||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -13.72% | -22.60% | 11.66% | 7.95% | 7.53% | 6.25% | -25.80% | -26.75% | -30.11% | -30.65% | -43.66% | -43.27% | -40.26% | -43.92% | -46.14% | -32.99% | -32.79% | -32.19% | -39.66% | -42.24% |